List view / Grid view
Thermo Fisher Scientific Inc., the world leader in serving science, today announced that Eastman Chemical Company, a large global manufacturer of chemicals, fibers and plastics, has expanded its deployment of Thermo Scientific SampleManager LIMS (laboratory information management system), which it has used since 2000 in its manufacturing quality control laboratories,…
13 May 2011 | By European Pharmaceutical Review
Pfizer will settle more than 2,200 lawsuits alleging the company's Wyeth unit hid Prempro's cancer risks...
13 May 2011 | By pSivida Corp.
A New Drug Application for the investigational drug ILUVIEN® for the treatment of diabetic macular edema (DME) has been resubmitted...
13 May 2011 | By Merck
VICTRELIS is approved for the treatment of CHC genotype 1 infection...
11 May 2011 | By Fleming Europe
Network with c-level industry leaders from AstraZeneca, Sanofi Aventis, Roche, Novartis, Baxter, Pfizer & Abbott...
10 May 2011 | By Sanofi Pasteur
The FDA approved Sanofi Pasteur’s sBLA for licensure of Fluzone Intradermal...
9 May 2011 | By AstraZeneca
New health economics data from a substudy of the PLATO trial...
9 May 2011 | By Evotec AG
Twelfth milestone triggers payment of EUR 2 million to Evotec...
9 May 2011 | By Elan Drug Technologies (EDT)
Alkermes will merge with EDT in a cash and stock transaction currently valued at approximately $960 million...
9 May 2011 | By Biogen Idec
The EMA Pediatric Committee has adopted an opinion agreeing to the pediatric investigational plan...
9 May 2011 | By Pfizer
Pfizer Inc. announced that the data from its two pivotal Phase 3 immunogenicity and safety trials of Prevnar 13®* (Pneumococcal 13-valent Conjugate Vaccine...
9 May 2011 | By Merck
Aim is to increase awareness, prevention and diagnosis of HCV infection....
6 May 2011 | By Cephalon Inc
Cephalon, Inc. presented positive results from a phase IV trial...
6 May 2011 | By Abbott
Abbott announced that the FDA approved the RX ACCULINK® Carotid Stent System...
5 May 2011 | By Novartis
Novartis announced today that the FDA approved Afinitor® (everolimus) tablets for the treatment of progressive neuroendocrine tumors of pancreatic origin (PNET)...
